These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21798424)

  • 1. Imaging atherosclerosis with F18-fluorodeoxyglucose positron emission tomography: What are we actually seeing?
    Wu JC; Nguyen PK
    J Am Coll Cardiol; 2011 Aug; 58(6):615-7. PubMed ID: 21798424
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
    Folco EJ; Sheikine Y; Rocha VZ; Christen T; Shvartz E; Sukhova GK; Di Carli MF; Libby P
    J Am Coll Cardiol; 2011 Aug; 58(6):603-14. PubMed ID: 21798423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and again, children resemble their parents.
    Hicks RJ
    J Nucl Med; 2008 Oct; 49(10):1577-8. PubMed ID: 18794271
    [No Abstract]   [Full Text] [Related]  

  • 4. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
    Blomberg BA; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New molecular probes of vascular inflammation.
    Vrachimis A; Honold L; Faust A; Hermann S; Schäfers M
    Q J Nucl Med Mol Imaging; 2016 Sep; 60(3):194-204. PubMed ID: 27280733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque.
    Alexanderson E; Slomka P; Cheng V; Meave A; Saldaña Y; García-Rojas L; Berman D
    J Nucl Cardiol; 2008; 15(6):841-3. PubMed ID: 18984461
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular molecular imaging: where art thou?
    Beller GA
    J Nucl Cardiol; 2008; 15(5):611-2. PubMed ID: 18761261
    [No Abstract]   [Full Text] [Related]  

  • 8. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preface to the special issue on quantitative imaging in cancer.
    Yankeelov TE; Gore JC
    Magn Reson Imaging; 2012 Nov; 30(9):1201-2. PubMed ID: 22898684
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic imaging of transient metabolic processes: PDT is just the beginning.
    Acton PD
    J Nucl Med; 2006 Jul; 47(7):1067-9. PubMed ID: 16818937
    [No Abstract]   [Full Text] [Related]  

  • 12. Imaging inflammation in atherosclerosis another step forward.
    Shah PK
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1223-5. PubMed ID: 19833313
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates.
    Basu S; Zhuang H; Alavi A
    Clin Nucl Med; 2007 Jul; 32(7):567-8. PubMed ID: 17581350
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
    Kai H
    Geriatr Gerontol Int; 2010 Jan; 10(1):1-8. PubMed ID: 20102376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and plaque inflammation.
    Rudd JH; Machac J; Fayad ZA
    J Am Coll Cardiol; 2007 May; 49(19):1991; author reply 1991-2. PubMed ID: 17498586
    [No Abstract]   [Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis.
    Harari OA; Al-Nahhas A; Jawad A
    Nucl Med Commun; 2008 Sep; 29(9):838-40. PubMed ID: 18677214
    [No Abstract]   [Full Text] [Related]  

  • 17. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR?
    Chen W; Dilsizian V
    J Nucl Med; 2015 Apr; 56(4):503-4. PubMed ID: 25722451
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
    Tahara N; Kai H; Nakaura H; Mizoguchi M; Ishibashi M; Kaida H; Baba K; Hayabuchi N; Imaizumi T
    Eur Heart J; 2007 Sep; 28(18):2243-8. PubMed ID: 17681956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).
    Rudd JH; Myers KS; Sanz J; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):379-88. PubMed ID: 18025992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of brain tumors.
    Fischman AJ
    Cancer Treat Res; 2008; 143():67-92. PubMed ID: 18619214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.